Back
Open Access

Poster session 2 - Cardiomyopathy

Event: ESC CONGRESS 2016
Topic: Miscellaneous
Session type: Poster Session
Date: 28 August 2016

Session

0
15 presentations in this session

Impact of papillary muscle hypertrophy in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis

Speaker: Doctor T. Kawamura (Osakasayama, JP)
Access
Abstract
0
Thumbnail

Influence of lifetime exposure to physical exercise on ventricular arrhythmias in patients with hypertrophic cardiomyopathy

Speaker: Doctor L. Dejgaard (Oslo, NO)
Access
Abstract
0
Thumbnail

Global and regional echocardiographic strain to assess early phase of hypertrophic cardiomyopathy due to sarcomeric mutations

Speaker: Professor P. Charron (Paris, FR)
Access
Abstract
Slides
0
Thumbnail

Prognostic significance of cardiopulmonary exercise testing in hypertrophic cardiomyopathy

Speaker: Professor C. Karvounis (Thessaloniki, GR)
Access
Abstract
Slides
0
Thumbnail

Yield of the cascade family screening strategy to identify athletes with inherited cardiac diseases.

Speaker: Mr J. Santos Mateo (Lorca, ES)
Access
Abstract
0
Thumbnail

Elimination of obstruction using alcohol septal ablation is associated with lower occurrence of cardiovascular mortality events in patients with hypertrophic obstructive cardiomyopathy

Speaker: Professor J. Veselka (Prague, CZ)
Access
Abstract
Slides
0
Thumbnail

Defining titin cardiomyopathy: genotype- phenotype correlations in a large prospective cohort of dilated cardiomyopathy patients

Speaker: Doctor U. Tayal (London, GB)
Access
Abstract
0
Thumbnail

Neuromuscular, pathological and genetic investigation in inherited cardiomyopathies

Speaker: Associate Professor G. Limongelli (Naples, IT)
Access
Abstract
0
Thumbnail

Yield of genetic testing in 97 consecutive cardiomyopathies patients through next-generation sequencing and a custom gene panel endorsing the HRS/EHRA expert consensus statement guidelines.

Speaker: Doctor M. Kotta (Milan, IT)
Access
Abstract
Slides
0
Thumbnail

Inflammation in cardiac amyloidosis correlates with poor prognosis

Speaker: Professor H. Schultheiss (Berlin, DE)
Access
Abstract
0
Thumbnail

15 speakers from this session

Doctor Takayuki Kawamura

Kinki University, Faculty of Medicine, Osakasayama (Japan)
0 follower

Doctor Lars Andreas Dejgaard

Center for Cardiological Innovation, Oslo (Norway)
0 follower

Professor Philippe Charron

AP-HP - Hospital Pitie-Salpetriere, Paris (France)
9 presentations
1 follower

Professor Charalampos Karvounis

, Thessaloniki (Greece)
0 follower

Mr Juan Jose Santos Mateo

Rafael Mendez Hospital, Lorca (Spain)
0 follower

Professor Josef Veselka

University Hospital Motol, CardioVascular Center, Prague (Czechia)
2 presentations
0 follower

Doctor Upasana Tayal

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

Associate Professor Giuseppe Limongelli

AO dei Colli - Monaldi Hospital, Naples (Italy)
2 presentations
0 follower

Doctor Maria-Christina Kotta

Scientific Institute Hospital San Michele, Milan (Italy)
0 follower

Professor Heinz-Peter Schultheiss

Institute of Cardiac Diagnostics and Therapy (IKDT), Berlin (Germany)
3 presentations
0 follower

Professor Alexandra Sousa

H. São João, Porto (Portugal)
0 follower

Doctor Denisa Jindrova

Charles University of Prague , Prague (Czechia)
0 follower

Mrs Yasmine Lisanne Hiemstra

Leiden University Medical Centre, Leiden (Netherlands (The))
0 follower

Doctor Arata Nomura

Tokyo Women's Medical University, Tokyo (Japan)
0 follower

Doctor Tatiyana Vaikhanskaya

Republican Scientific and Practical Center "Cardiology", Minsk (Belarus)
0 follower

This platform is supported by

logo Novo Nordisk